Archives

10
Jan

Giovanni M. Pitari, M.D., Ph.D. receives award from the American Institute for Cancer Research

Giovanni M. Pitari, M.D., Ph.D., has received an award from the American Institute for Cancer Research to support his research project entitled ‘Therapeutic Synergy between Dietary Calcium and Bacterial Enterotoxins for the Prevention and Treatment of Colon Cancer’. The award provides research funding directed toward discovering innovative therapeutic modalities for cancer prevention and cure. Dr. …

24
Aug

15th Anniversary Celebration of the First Transplant Performed by the Bone Marrow Transplant Program at Thomas Jefferson University Hospital

On September 29, 2010 there will be a celebration to mark the 15th anniversary of the first transplant performed by the Bone Marrow Transplant Program at Thomas Jefferson University Hospital. Under the leadership of Dr. Neal Flomenberg, who established the BMT program at Jefferson in 1995, there have been approximately 650 transplants performed to date.

13
Aug

Free Prostate Cancer Screenings

The Kimmel Cancer Center at Jefferson and Prostate Health International’s Gary Papa Run are offering free prostate screenings as part of a research program. Prostate cancer is the second leading cause of cancer death among men. Screening is important because prostate cancer shows no symptoms in its earliest stages.

30
Jun

ACS-IRG Pilot Projects Awarded for 2010

The Kimmel Cancer Center at Jefferson hosted the 3rd Annual ACS-IRG Luncheon on June 16, 2010. The 2010 Pilot Project recipients are Nancy Hodgson, RN, PhD of the Jefferson Center for Applied Research in Aging and Health, Amy Leader, DrPh, MPh and Hushan Yang, PhD, both of the department of Medical Oncology.

24
May

Scientists Find Protein Spurs Spread of Prostate Cancer

Researchers from the Kimmel Cancer Center at Jefferson have found that Stat5, a signaling protein previously found to be key to survival of prostate cancer, is also involved in metastasis. Their study, published in the online edition of Endocrine-Related Cancer, demonstrates in both laboratory and animal models that nuclear Stat5 over-expression leads to a deadly …

24
May

Adam P. Dicker Appointed Chairman of Radiation Oncology at Thomas Jefferson University

Adam P. Dicker, M.D., Ph.D., has been appointed chairman of the department of Radiation Oncology at Jefferson Medical College of Thomas Jefferson University. Dr. Dicker is an international authority in radiation oncology, drug development, and the treatment of prostate cancer and brain tumors. Dr. Dicker co-leads the Radiation Research and Translational Biology Program at the …

19
May

Small RNA Molecules Block Breast Cancer from Spreading via Newly Identified Secreted Factor

The role of genes and proteins in cancer control is well known, but now researchers at Jefferson’s Kimmel Cancer Center have found a cluster of microRNA (miRNA) molecules that act to suppress the invasive spread of breast cancer. MiRNAs are non-coding small RNA molecules found in wide areas of the genome that, either singly or …

19
May

Kimmel Cancer Center Director Awarded R. Douglas Wright Medallion at the University of Melbourne, Australia

Richard G. Pestell, M.D., Ph.D., FACP, FRACP, Director of the Kimmel Cancer Center at Jefferson, was honored with the R. Douglas Wright Medallion and delivered the R. Douglas Wright Lecture at the University of Melbourne in Australia. The award is given in the areas of science, literature, economics and politics. Prior recipients include Sir James …

19
May

Clue to Switch of Bladder Cancer from Locally Contained to Invasive Found by Jefferson Scientists

Bladder cancer often becomes aggressive and spreads in patients despite treatment, but now researchers at the Kimmel Cancer Center at Jefferson have identified a protein they believe is involved in pushing tumors to become invasive – and deadly. “We have found that IGF-IR is a critical regulator of motility and invasion of bladder cancer cells, …

19
May

Jefferson Scientists Unlock Secret to Powerful Tumor Suppressor That Can Reverse Cancer Progression

Researchers at the Kimmel Cancer Center at Jefferson have discovered how a powerful tumor suppressor called DACH1 works – a finding that explains why restoring its lost function in cancer cells pushes them to become normal again. In the March 29 online early edition of the Proceedings of the National Academy of Sciences (PNAS), the …

12
Apr

Cancer Programs Celebrate National Cancer Registrars Week to Emphasize Value of Cancer Registrars April 12-16, 2010

Theme of “Cancer Registrars are Recording Artists” Spotlights the Key Role Cancer Registrars play in enabling Cancer Research and Control Cancer Registrars will join with their colleagues worldwide to observe the annual National Cancer Registrars Week, April 12th-16th. The 2010 theme “Cancer Registrars are Recording Artists” demonstrates Cancer Registrars as being the first link in …

30
Mar

Karen Knudsen receives Richard E. Weitzman Memorial Award

Karen Knudsen, PhD, Associate Professor, Department of Cancer Biology and Urology at the Kimmel Cancer Center received the Richard E. Weitzman Memorial Award from the Endocrine Society. This annual Laureate Awards annual award recognizes an exceptionally promising young clinical or basic investigator. Knudsen is recognized for scientific achievements in the study of androgen action in …